NCT07472881 Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women
| NCT ID | NCT07472881 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Menopause |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-03-16 |
| Primary Completion | 2029-01-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-03-16 with a primary completion date of 2029-01-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to integrate Traditional Chinese Medicine (TCM) theory and therapeutic methods with modern low-level laser stimulation on corresponding acupoints, applying this combined approach to the field of weight management in menopausal women. The trial aims to investigate whether lifestyle modifications in accordance with WHO guidelines (dietary control and exercise), combined with adjunctive low-level laser acupuncture, can enhance weight reduction and improve body composition more effectively than standard lifestyle interventions alone.
Eligibility Criteria
Inclusion Criteria: * Female participants aged 45 to 55 years * No cognitive impairment or major psychiatric disorder * Able to understand the study procedures and communicate with research staff * Body mass index (BMI) \> 24 kg/m² OR waist-to-hip ratio \> 0.88 Exclusion Criteria: * Pregnant or possibly pregnant women * Diagnosed chronic diseases currently under active treatment, including hepatitis, chronic kidney disease, chronic gastrointestinal disease, cardiovascular disease, or cancer * Systemic diseases such as hyperthyroidism, hypothyroidism, compensated liver cirrhosis, or autoimmune disorders * Currently receiving weight control treatment, including bariatric surgery or weight-loss medications * History of epilepsy or seizure disorder * Coagulation disorders or current use of anticoagulant therapy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07472881 clinical trial?
This trial is open to female participants only, aged 45 Years or older, up to 55 Years, studying Menopause. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07472881 currently recruiting?
Yes, NCT07472881 is actively recruiting participants. Contact the research team at yenlin@cgmh.org.tw for enrollment information.
Where is the NCT07472881 trial being conducted?
This trial is being conducted at Keelung, Taiwan.
Who is sponsoring the NCT07472881 clinical trial?
NCT07472881 is sponsored by Chang Gung Memorial Hospital. The trial plans to enroll 40 participants.